Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Clinical trial NCT01260701 · COMPLETED

Trial details

NCT number: NCT01260701
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Gastroesophageal Junction Diffuse Gastric Adenocarcinoma Gastric Intestinal Type Adenocarcinoma Gastric Mixed Adenocarcinoma Recurrent Gastric Carcinoma

Start date: 2011-01-01
Primary completion: 2014-05-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.